BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 6 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,318,201 | -10.7% | 464,321 | +12.3% | 1.41% | -0.7% |
| Q2 2023 | $26,122,266 | +61.8% | 413,327 | +15.2% | 1.42% | +48.5% |
| Q1 2023 | $16,143,312 | +20.5% | 358,820 | +17.4% | 0.95% | +15.1% |
| Q4 2022 | $13,393,111 | -19.9% | 305,709 | +20.5% | 0.83% | -21.5% |
| Q3 2022 | $16,713,000 | -29.8% | 253,645 | +14.1% | 1.06% | +25.9% |
| Q4 2021 | $23,802,000 | -5.7% | 222,217 | -9.5% | 0.84% | -4.0% |
| Q3 2021 | $25,246,000 | +16.9% | 245,557 | 0.0% | 0.87% | +23.6% |
| Q2 2021 | $21,599,000 | -20.4% | 245,557 | -12.0% | 0.71% | -21.4% |
| Q1 2021 | $27,126,000 | -14.2% | 278,986 | -1.0% | 0.90% | -18.1% |
| Q4 2020 | $31,597,000 | -6.5% | 281,739 | -22.7% | 1.10% | -26.6% |
| Q3 2020 | $33,777,000 | +21.2% | 364,373 | +2.0% | 1.50% | +13.8% |
| Q2 2020 | $27,870,000 | +31.0% | 357,302 | -1.8% | 1.32% | -1.3% |
| Q1 2020 | $21,273,000 | – | 363,772 | – | 1.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 716,539 | $36,192,000 | 12.35% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,020,629 | $102,062,000 | 6.89% |
| Casdin Capital, LLC | 1,150,000 | $58,087,000 | 4.91% |
| DAFNA Capital Management LLC | 261,280 | $13,197,000 | 3.60% |
| Nextech Invest Ltd. | 188,228 | $9,507,000 | 3.21% |
| Eagle Health Investments LP | 170,551 | $8,615,000 | 2.01% |
| Boxer Capital, LLC | 507,374 | $25,627,000 | 1.62% |
| Rock Springs Capital Management LP | 979,174 | $49,458,000 | 1.44% |
| EFG Asset Management (North America) Corp. | 130,454 | $6,589,000 | 1.39% |
| Integral Health Asset Management, LLC | 130,000 | $6,566,000 | 1.35% |